Clinical Pharmacology in Athletic Training

Michelle Cleary, PhD, ATC, is an associate professor in the physician assistant studies program in the Crean College of Health and Behavioral Science at Chapman University. Prior to joining Chapman in 2012, Cleary taught at Temple University, where she earned her doctorate, and at Florida International University and the University of Hawaii. She is certified as an athletic trainer by the Board of Certification (BOC). She has 20 years of experience teaching in accredited athletic training programs.In addition to numerous journal articles and book chapters, Cleary has written two national position statements for the National Athletic Trainers’ Association (NATA), has served on several NATA committees, and received the Most Distinguished Athletic Trainer award from NATA in 2019. Cleary wrote Acute and Emergency Care in Athletic Training with Katie Walsh Flanagan. She is the chair of the Research and Grants Committee of the Far West Athletic Trainers’ Association and is also an active member of the California Athletic Trainers’ Association, receiving the Outstanding Service Award in 2015. Her clinical experience includes time as an athletic trainer at the high school, NCAA Division I, and international/Olympic levels.Thomas E Abdenour, DHSc, ATC, CES, received his doctorate degree in health science from A.T. Still University in 2011. He is a member of the National Athletic Trainers’ Association (NATA) and is currently on the NATA’s Foundation Board. Abdenour was inducted into the NATA Hall of Fame in 2007 and received the Most Distinguished Athletic Trainer award from NATA in 2014. He contributed to the 2009 NATA consensus statement Managing Prescription and Non-Prescription Medication in the Athletic Training Facility.Abdenour is best known for his work in the National Basketball Association, where he spent 23 years as the head athletic trainer for the Golden State Warriors. In 1990, he was recognized as the Athletic Trainer of the Year by the National Basketball Athletic Trainers Association. Abdenour served as athletic trainer for the gold-medal-winning USA men's basketball team at the 2000 Summer Olympics in Sydney, Australia. He also founded the Champion Guidance Center for Men in Oakland, California, to support underprivileged men. Following his time with the Golden State Warriors, he served as the head athletic trainer at San Diego State University. While at San Diego State University, he was an approved clinical instructor and an adjunct faculty member in the department of exercise and nutrition science.Michael Pavlovich, PharmD, earned his doctor of pharmacy degree in 1989 from the University of the Pacific. He is currently the president and owner of Westcliff Compounding Pharmacy. Pavlovich was an American Pharmacists Association (APhA) trustee from 2008 to 2014 and served in the APhA House of Delegates for more than 25 years. He received the Distinguished Achievement Award in Specialized Pharmacy Practice from APhA in 2012 and was recognized for his influence on the practice of pharmaceutical compounding and sports medicine. He is a past president of the California Pharmacists Association and a past board member of Pharmaceutical Care Network.Prior to his employment at Westcliff Compounding Pharmacy, Pavlovich was the chief pharmacist for SportPharm, which revolutionized athletic trainers’ capacity to manage prescription medications under the guidance of a team physician. He served as team pharmacist on the U.S. Olympic medical team at the 2008 Summer Olympics in Beijing, China. Pavlovich also contributed to the 2009 NATA consensus statement Managing Prescription and Non-Prescription Medication in the Athletic Training Facility. Many of his core recommendations for medication management in the athletic training clinic are still being followed today.

• Part I. Foundational Pharmacology ConceptsChapter 1. Legal Aspects of Therapeutic Medication ManagementHealth Care Providers With Prescribing AuthorityThe Sports Medicine TeamFederal and State LawsDrug Development, Studies, and StandardsSummaryCase StudiesChapter 2. Administering Medications in the Athletic Training SettingAthletic Training ClinicGuidelines for Administering MedicationsPreventing Medication ErrorsSummaryCase StudiesChapter 3. Drug Names, Classification, and SafetyDrug NamesDrug ClassesDrug SafetyAdverse Drug Effects and Therapeutic MonitoringAllergic Drug ReactionsMedication Use ProcessDrug Information ResourcesSummaryCase StudiesChapter 4. PharmacokineticsBiopharmaceuticsDrug LiberationDrug AbsorptionDrug DistributionDrug MetabolismDrug EliminationPharmacokinetics and ExerciseSummaryCase StudiesChapter 5. PharmacodynamicsMechanism of ActionDrug ReceptorsDrug–Receptor BindingDrug–Receptor InteractionsDrug DosingDose ResponsesSummaryCase StudiesChapter 6. Drug Delivery, Dosages, and ProceduresDrug Delivery SystemsRoutes of AdministrationEnteral Drug DeliveryParenteral Drug DeliveryMucous Membrane Drug AdministrationTopical Drug AdministrationTransdermal Drug AdministrationMedication DosingClinical Procedures for Enteral Drug AdministrationSummaryCase StudiesPart II. Classes of Therapeutic MedicationsChapter 7. Drugs to Treat Pain: Nonopioid Analgesics and AnestheticsBiopsychosocial ModelDifferentiation of PainPathophysiology of PainAnalgesicsNonopioid Analgesic AgentsLocal AnestheticsTopical Analgesics: Creams, Gels, and OintmentsThe ATs’ Role in the Clinical Management of PainSummaryCase StudiesChapter 8. Drugs to Treat Pain: Opioid AnalgesicsAppropriate Use of Opioid AnalgesicsClasses of Opioid AnalgesicsSummaryCase StudiesChapter 9. Drugs to Treat Inflammation: Steroidal and Nonsteroidal Anti-InflammatoriesInflammatory ProcessControlling InflammationCorticosteroidsNonsteroidal Anti-Inflammatory DrugsSummaryCase StudiesChapter 10. Drugs to Treat Infection: AntibioticsIndications for UseMechanism of ActionTherapeutic EffectsRoutes of AdministrationPharmacokineticsPharmacodynamicsDosing GuidelinesAdverse EffectsIndications and PrecautionsPatient Education for Use of Antibacterial MedicationsSummaryCase StudiesPart III. Drugs for Treating Common ConditionsChapter 11. Drugs for Treating Asthma and Other Respiratory ConditionsRespiratory InfectionsAllergic Rhinitis and Other AllergiesAsthmaSummaryCase StudiesChapter 12. Drugs for Treating Cardiovascular ConditionsIschemic Chest Pain: Angina PectorisAtherosclerosis and Coronary Artery DiseaseAcute Coronary SyndromeHypertension and Hypertensive CrisisCardiac ArrhythmiasThromboembolismsSummaryCase StudiesChapter 13. Drugs for Treating Diabetes and Disordered Glucose MetabolismGlucose HomeostasisMetabolic DisordersAntidiabetic Agents for Managing Type 2 Diabetes MellitusInsulin for Managing Type 1 and Type 2 Diabetes MellitusDiabetes Care PlanSummaryCase StudiesChapter 14. Drugs for Treating Digestive DisordersNausea and VomitingDiarrheaConstipationGastroesophageal Reflux DiseaseGastritis and Peptic Ulcer DiseaseGastroenteritisFunctional Bowel Disorders: Inflammatory Bowel DiseaseSupportive Care and General Management of Digestive DisordersSummaryCase StudiesChapter 15. Drugs for Treating Common Musculoskeletal and Neurological ConditionsArticular (Joint) PainMusculotendinous PainNeck and Back PainFibromyalgiaComplex Regional Pain SyndromeHeadache DisordersSummaryCase StudiesChapter 16. Drugs for Treating Dermatological ConditionsProtective Barrier of the SkinPrinciples of Topical Dermatologic PharmacologyBacterial Skin and Soft-Tissue InfectionsFungal Skin InfectionsCandidiasisViral Skin Infections: Herpes Simplex and Molluscum ContagiosumAutoimmune Inflammatory Skin ConditionsSummaryCase StudiesChapter 17. Drugs for Treating Reproductive and Genitourinary ConcernsFamily Planning and ContraceptionShort-Acting Hormonal ContraceptivesLong-Acting Reversible ContraceptionBarrier MethodsEmergency ContraceptionRecommendations for Exercise During PregnancySexually Transmitted InfectionsReproductive and Urogenital ConcernsSummaryCase StudiesChapter 18. Drugs for Treating Mental Health ConditionsMental Health ConditionsBehavioral Health EmergenciesTreatment Options for Mental Health DisordersMood DisordersAnxiety DisordersStressor-Related DisordersSleep or Wakefulness DisordersNeurodevelopmental Disorders: Attention-Deficit/Hyperactivity DisorderEating DisordersSubstance-Related DisordersSummaryCase StudiesChapter 19. Drugs and Supplements to Enhance PerformanceSubstances Banned for CompetitionSupplements for Enhancing Musculoskeletal PerformanceSupplements for Treating Neurological ConditionsSupplements for Treating Skeletal ConditionsManipulation of Approved Medications to Enhance PerformanceSummaryCase StudiesChapter 20. Cannabis and CannabinoidsCannabisCannabinoidsAcute Effects of Cannabis UseChronic Effects of Cannabis UseAdverse Effects of CannabisCannabidiolMedical CannabinoidsResearch on Cannabinoid-Based MedicinesPerformance Effects and Sport RegulationRegulation of Cannabis UseClinical RecommendationsSummaryCase StudiesChapter 21. Drug Testing in SportDrug EducationThe Evolution of Drug Testing in SportSupplement StandardsThe Drug-Testing ProcessTesting for MarijuanaTesting for Anabolic SteroidsMasking AgentsResults of Drug TestingDrug ExemptionsSummaryCase StudiesChapter 22. Medications for SurgeryConcepts of AnesthesiaEffects of General AnesthesiaLevels of SedationStages of AnesthesiaTypes of AnesthesiaCommon Applications of Anesthesia in Sports MedicinePreparation for a Surgical ProcedureRecovery From a Surgical ProcedureAdverse Effects of AnesthesiaSummaryCase Studies

Select Guide Rating